List of Milprosa drug patents

Milprosa is owned by Ferring Pharms Inc.

Milprosa contains Progesterone.

Milprosa has a total of 3 drug patents out of which 0 drug patents have expired.

Milprosa was authorised for market use on 29 April, 2020.

Milprosa is available in system;vaginal dosage forms.

Milprosa can be used as method of supporting embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology (art) treatment program for infertile women.

The generics of Milprosa are possible to be released after 21 January, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10548904 FERRING PHARMS INC Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Feb, 2029

(5 years from now)

US10537584 FERRING PHARMS INC Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Feb, 2029

(5 years from now)

US8580293 FERRING PHARMS INC Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Jan, 2030

(6 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Apr 29, 2023

Drugs and Companies using PROGESTERONE ingredient

Market Authorisation Date: 29 April, 2020

Treatment: Method of supporting embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology (art) treatment program for infertile women

Dosage: SYSTEM;VAGINAL

More Information on Dosage

MILPROSA family patents

7

United States

3

New Zealand

3

Taiwan, Province of China

3

Korea, Republic of

2

Portugal

2

Singapore

2

Spain

2

China

2

EA

2

South Africa

2

Canada

2

Japan

2

Slovenia

2

Israel

2

Poland

2

Denmark

2

European Union

1

Brazil

1

Croatia

1

Argentina

1

Mexico

1

Lithuania

1

Hungary

1

Chile

1

Australia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in